RedHill Biopharma Ltd 20-F for FY2024
RedHill Biopharma Ltd. (RDHL)
20-F
2025-04-10
For: 2024-12-31
View Original
Added on
April 07, 2026
About this 20-F
RedHill Biopharma Ltd filed this 20-F on April 10, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $8.04M
- up 23.2% from $6.53M a year earlier
- Net loss
- $8.27M
- compared with net income of $23.92M a year earlier
- Diluted EPS
- $0.00
- compared with $0.01 a year earlier